Cargando…
Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia
Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The inta...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468876/ https://www.ncbi.nlm.nih.gov/pubmed/32784915 http://dx.doi.org/10.3390/nu12082386 |
_version_ | 1783578307474751488 |
---|---|
author | Ramírez-Tejero, Jorge A. Martínez-Lara, Esther Peinado, M Ángeles del Moral, María Luisa Siles, Eva |
author_facet | Ramírez-Tejero, Jorge A. Martínez-Lara, Esther Peinado, M Ángeles del Moral, María Luisa Siles, Eva |
author_sort | Ramírez-Tejero, Jorge A. |
collection | PubMed |
description | Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The intake of extra virgin olive oil, and particularly of one of its phenolic compounds, hydroxytyrosol (HT), has proven to be protective in terms of redox homeostatic balance and the reduction of inflammation. In this context, using a proteomic approach with nanoscale liquid chromatography coupled to tandem mass spectrometry, the present study analysed: (i) Changes in the proteome of dermal fibroblasts from a patient with FM versus a healthy control, and (ii) the effect of the treatment with a nutritional relevant dose of HT. Our results unveiled that fibroblast from FM show a differential expression in proteins involved in the turnover of extracellular matrix and oxidative metabolism that could explain the inflammatory status of these patients. Moreover, a number of these proteins results normalized by the treatment with HT. In conclusion, our results support that an HT-enriched diet could be highly beneficial in the management of FM. |
format | Online Article Text |
id | pubmed-7468876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74688762020-09-04 Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia Ramírez-Tejero, Jorge A. Martínez-Lara, Esther Peinado, M Ángeles del Moral, María Luisa Siles, Eva Nutrients Article Fibromyalgia (FM) is a chronic and highly disabling syndrome, which is still underdiagnosed, with controversial treatment. Although its aetiology is unknown, a number of studies have pointed to the involvement of altered mitochondrial metabolism, increased oxidative stress and inflammation. The intake of extra virgin olive oil, and particularly of one of its phenolic compounds, hydroxytyrosol (HT), has proven to be protective in terms of redox homeostatic balance and the reduction of inflammation. In this context, using a proteomic approach with nanoscale liquid chromatography coupled to tandem mass spectrometry, the present study analysed: (i) Changes in the proteome of dermal fibroblasts from a patient with FM versus a healthy control, and (ii) the effect of the treatment with a nutritional relevant dose of HT. Our results unveiled that fibroblast from FM show a differential expression in proteins involved in the turnover of extracellular matrix and oxidative metabolism that could explain the inflammatory status of these patients. Moreover, a number of these proteins results normalized by the treatment with HT. In conclusion, our results support that an HT-enriched diet could be highly beneficial in the management of FM. MDPI 2020-08-09 /pmc/articles/PMC7468876/ /pubmed/32784915 http://dx.doi.org/10.3390/nu12082386 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ramírez-Tejero, Jorge A. Martínez-Lara, Esther Peinado, M Ángeles del Moral, María Luisa Siles, Eva Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title_full | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title_fullStr | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title_full_unstemmed | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title_short | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia |
title_sort | hydroxytyrosol as a promising ally in the treatment of fibromyalgia |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468876/ https://www.ncbi.nlm.nih.gov/pubmed/32784915 http://dx.doi.org/10.3390/nu12082386 |
work_keys_str_mv | AT ramireztejerojorgea hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia AT martinezlaraesther hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia AT peinadomangeles hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia AT delmoralmarialuisa hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia AT sileseva hydroxytyrosolasapromisingallyinthetreatmentoffibromyalgia |